Inflammatory Biomarkers to Detect Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Lung Cancer Patients: Ready for Prime Time?

JACC CardioOncol. 2020 Sep 15;2(3):503-505. doi: 10.1016/j.jaccao.2020.08.001. eCollection 2020 Sep.

Authors

Mandar A Aras¹, John R Power², Javid J Moslehi²

Affiliations

¹ Division of Cardiology, University of California-San Francisco, San Francisco, California, USA.
² Cardio-Oncology Program, Divisions of Cardiovascular Medicine and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

No abstract available

Keywords: immune checkpoint inhibitors; inflammatory markers; myocarditis; neutrophil-to-lymphocyte ratio.

Publication types

Editorial

Grants and funding